Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche culls cough candidate, pivots KRAS program after revaluing entire pipeline
Fierce Biotech
Wed, 10/23/24 - 11:29 am
Tags:
Roche, chronic cough, KRAS, Genentech
Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Fierce Biotech
Tue, 10/22/24 - 11:25 am
Tags:
Roche, UCB Pharma, anti-tau antibodies, bepranemab, Alzheimer's disease
Roche reports topline data from trial of Vabysmo for diabetic macular edema
Clinical Trials Arena
Mon, 10/21/24 - 09:44 am
Tags:
Roche, Vabysmo, diabetic macular edema
Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review
Fierce Biotech
Fri, 10/18/24 - 11:34 am
Tags:
Roche, MAGE-A4, clinical trials, solid tumors, bispecific antibodies, Genentech
Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche’s Tecentriq
Fierce Pharma
Tue, 10/15/24 - 11:03 am
Tags:
Jazz Pharma, Zepzelca, extensive-stage small cell lung cancer, Roche, Tecentriq
Genentech’s Evrysdi helped babies with SMA reach rare milestones in Phase II trial
Clinical Trials Arena
Tue, 10/15/24 - 10:16 am
Tags:
Roche, SMA, spinal muscular atrophy, Evrysdi, clinical trials
Roche gets FDA green light for breast cancer drug Itovebi
Pharmaphorum
Fri, 10/11/24 - 09:34 am
Tags:
Roche, FDA, Itovebi, metastatic breast cancer
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed
Reuters
Wed, 10/9/24 - 09:44 am
Tags:
Roche, breast cancer, Giredestrant, clinical trials
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
Tags:
R&D, obesity, weight loss, Novo Nordisk, Eli Lilly, Roche, Boehringer Ingelheim
Genentech buys Regor's next-gen CDK inhibitors for $850M
Pharmaphorum
Tue, 10/1/24 - 09:46 am
Tags:
Regor Therapeutics, Roche, Genentech, CDK inhibitors
Roche targets more than $3 billion in annual obesity sales
Reuters
Mon, 09/30/24 - 10:09 am
Tags:
Roche, Carmot Therapeutics, obesity, diabetes
Roche looks to grow Gazyva's reach with phase 3 lupus nephritis win
Fierce Pharma
Thu, 09/26/24 - 06:27 pm
Tags:
Roche, Gazyva, clinical trials, lupus nephritis
Roche reports positive data from Phase III influenza treatment trial
Clinical Trials Arena
Thu, 09/19/24 - 09:24 am
Tags:
Roche, Flu, clinical trials, Xofluza
Obesity pill race heats up as Novo, Roche and Terns share data
BioSpace
Tue, 09/17/24 - 11:22 am
Tags:
obesity, Novo Nordisk, Roche, Terns Pharmaceuticals, amycretin, TERN-601, CT-996, clinical trials
Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
Fierce Pharma
Sun, 09/15/24 - 06:17 pm
Tags:
Roche, Genentech, Ocrevus, MS, Ocrevus Zunovo
FDA approves Roche’s Tecentriq Hybreza for cancer
Yahoo Finance
Fri, 09/13/24 - 09:33 am
Tags:
Roche, FDA, Tecentriq Hybreza, cancer
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Fierce Biotech
Wed, 09/11/24 - 11:15 pm
Tags:
Roche, obesity, CT-388, Carmot Therapeutics
Roche ramps up R&D with $1.4B Swiss facility
Fierce Biotech
Wed, 09/11/24 - 11:55 am
Tags:
Roche, R&D, Switzerland
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
Tags:
weight loss, obesity, Amgen, Pfizer, Roche, Novo Nordisk, Eli Lilly, Boehinger Ingelheim, Structure Therapeutics, Viking Therapeutics, Zealand Pharma, Altimmune
Genentech's cancer restructure was made 'for scientific reasons': exec
Fierce Biotech
Tue, 09/10/24 - 08:44 am
Tags:
Genentech, Roche, restructuring

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.